• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

Pavmed

7 medtech stores we missed this week: March 10, 2017

March 10, 2017 By Danielle Kirsh

The FDA and Health Canada cleared a couple medical devices while other companies touted their device studies. Here are 7 medtech stories we missed this week but were still worth mentioning. 1. FDA clears Medela’s neonatal enteral feeding device Medela has received 510(k) clearance from the FDA to market its ENFit Low Dose Tip eternal […]

Filed Under: Biotech, Cardiac Implants, Cardiovascular, Clinical Trials, Regulatory/Compliance, Spine Tagged With: Abiomed, Exact Imaging, IntelliJoint Surgical, InVivo Therapeutics, Medela, Nexstim, Pavmed

Pavmed announces upcoming exchange offering

February 23, 2017 By Fink Densford

Pavmed (NSDQ:PAVMU) today announced an upcoming registered exchange offering, looking to make its common stock exchangeable for units. Each unit in the offering from the New York-based company will be comprised of a share of common stock and a newly issued warrant, which will be exercisable for a share of common stock at an exercise price […]

Filed Under: Business/Financial News Tagged With: Pavmed

PAVmed raises $1.5m in private placement

February 2, 2017 By Fink Densford

PAVmed Inc. (NSDQ:PAVMU) said today it raised $1.5 million through a private placement of Series A convertible preferred stock and Series A warrants, with funds slated to support FDA clearance of its 1st product, the PortIO intraosseous infusion system. The New York-based company said it is hopeful for for FDA 510(k) clearance for the PortIO by the […]

Filed Under: Business/Financial News Tagged With: Pavmed

PAVmed partners with Boston institutions for antibiotic-eluting ear device

November 7, 2016 By Sarah Faulkner

PAVmed Inc. (NSDQ:PAVMU) said today that it inked an exclusive licensing agreement with academic institutions to develop and commercialize antibiotic-eluting resorbable ear tubes based on an aqueous silk technology designed by the institutions. The licensing deal includes agreements with Tufts University, Massachusetts Eye & Ear Infirmary and Massachusetts General Hospital, who developed the aqueous silk technology. As […]

Filed Under: Business/Financial News, Drug-Device Combinations, Drug-Eluting Stents, Research & Development, Respiratory Tagged With: Massachusetts Eye & Ear Infirmary, Massachusetts General Hospital, Pavmed, Tufts University

Haemonetics taps ex-Medtronic CIO Burke as new CFO | Personnel Moves August 4, 2016

August 4, 2016 By Fink Densford

Haemonetics taps ex-Medtronic CIO Burke as new CFO   Haemonetics (NYSE:HAE) said this week it tapped former Medtronic (NYSE:MDT) chief integration officer William Burke as its new chief financial officer, effective August 8. Burker operated as CIO with Medtronic since 2015, serving during the integration of Covidien. Prior to that, he held various finance positions with […]

Pages: Page 1 Page 2 Page 3 Page 4 Page 5

Filed Under: Business/Financial News Tagged With: Bausch + Lomb, Covidien, Danaher Corp., Haemonetics, LivaNova, Medtronic, Pavmed, Personnel Moves, Radiology Protocols, ReVision Optics Inc., Zimmer Biomet

Pavmed eyes Q4 FDA submission for PortIO vascular access device

July 14, 2016 By Brad Perriello

Pavmed (NSDQ:PAVMU) said today that it’s planning to submit an application for FDA clearance for its 1st product, the PortIO long-term implantable vascular access device, during the 4th quarter. New York City-based Pavmed said the PortIO device is in the verification and validation testing phase, the final stage of pre-submission testing. The company has 4 other […]

Filed Under: Food & Drug Administration (FDA), Regulatory/Compliance, Vascular Tagged With: Pavmed

Pavmed IPO grosses $5.3m

April 28, 2016 By Brad Perriello

Updated with the correct stock ticker for currently trading Pavmed units (PAVMU) Pavmed said today that its initial public offering grossed $5.3 million, after extending the flotation last month for an extra 45 days. Pavmed is developing devices in 5 areas, according to its IPO registration: The PortIO long-term implantable vascular access device; the Caldus line […]

Filed Under: Funding Roundup, Initial Public Offering (IPO), Wall Street Beat Tagged With: Pavmed

Pavmed extends $6m IPO

March 18, 2016 By Fink Densford

Pavmed said earlier this week it will extend its heavily reduced $6 million IPO an additional 45 days. The IPO was dramatically reduced in January, with the company announcing that it planned to float a reduced 1.2 million shares at $5 a piece. Pavmed expects the IPO to bring in $5.4 million after sales commissions but […]

Filed Under: Business/Financial News Tagged With: Pavmed

Pavmed scales back IPO to $6m

January 25, 2016 By Brad Perriello

Pavmed last week dramatically trimmed its pending initial public offering, saying it plans to float 1.2 million shares at $5 apiece for gross proceeds of $6 million. That’s a far cry from the $23 million top end Pavmed listed when it registered the IPO last May. Pavmed is developing devices in 5 areas, according to its […]

Filed Under: Funding Roundup, Initial Public Offering (IPO), Wall Street Beat Tagged With: Cruzar Medsystems, Kaleidoscope Medical, Pavilion Medical Innovations, Pavmed, Saphena Medical, Vortex Medical

BSX aims for double-digit earnings growth | Medtech Wall Street news for the week of May 4, 2015

May 7, 2015 By MassDevice Leave a Comment

Boston Scientific aims for double-digit earnings growth

May 1, 2015 by Brad Perriello

Filed Under: News Well, Wall Street Beat Tagged With: Boston Scientific, Carmat Inc., Cruzar Medsystems, Euronext, Kaleidoscope Medical, Pavilion Medical Innovations, Pavmed, Profound Medical Inc., Saphena Medical, Vortex Medical

Pavmed files for $23m IPO

May 4, 2015 By Brad Perriello Leave a Comment

Pavmed files for $23m IPO

The entrepreneurs behind a quartet of medical device companies is betting their formula can cut down on the time and cost of getting medtech to market with a $23 million initial public offering.

Filed Under: Initial Public Offering (IPO), News Well, Wall Street Beat Tagged With: Cruzar Medsystems, Kaleidoscope Medical, Pavilion Medical Innovations, Pavmed, Saphena Medical, Vortex Medical

  • « Go to Previous Page
  • Go to page 1
  • Interim pages omitted …
  • Go to page 3
  • Go to page 4
  • Go to page 5

Primary Sidebar

DeviceTalks Weekly

May 27, 2022
Quick message - No DTW podcast, but plenty else to listen to over this weekend and next week.
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS